Kiniksa Pharmaceuticals COO Moat Ross exercised Options covering 8,285 shares across multiple transactions on September 1, 2026. The same date included a 4,007-share forfeiture at $79.28 per share, awards of 46,200 derivative securities at $0 per share, and post-transaction holdings of 16,307 shares and 36,950 derivatives.

Key Highlights

  • Moat Ross forfeited 4,007 Kiniksa Pharmaceuticals shares at $79.28 per share.
  • The COO received 46,200 derivative securities at $0 per share.
  • Ross held 16,307 shares and 36,950 derivative securities after the transactions.

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) Chief Operating Officer Moat Ross exercised options covering 8,285 shares, leaving him with 20,314 shares afterward. The Equity transactions took place on September 1, 2026.

Ross’s Share and Derivative Position Changes

Ross forfeited 4,007 Kiniksa Pharmaceuticals shares at $79.28 per share on September 1, 2026, after which his share ownership stood at 16,307. The same date included awards totaling 46,200 derivative securities at $0 per share. Ross held 36,950 derivative securities after those awards. Ross also exercised options covering 8,285 derivative securities at $0 per share.